Harmony Biosciences Acquires Asset With Novel Mechanism Of Action For The Potential Treatment Of Narcolepsy And Other Rare Neurological Diseases
- Monday, August 9, 2021, 7:11
- PR Newswire
- Add a comment
PLYMOUTH MEETING, Pa., Aug. 9, 2021 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological diseases, today announced the acquisition…
About the Author
admin has written 21729 stories on this site.